Business Roundtable
Doing a Transformative Deal
Monday, February 12, 2007
9:30 AM
Conrad Suite
Life science companies' first deals are often the most transformative, providing validation, financial foundation, the means to progress innovative science. This panel explores the many ways a company can "transform" itself and the subsequent valuations achieved.
Moderators
- Peter L. Korn, Jr.; Prinicpal, Fish & Richardson P.C.
Panelists
- Joshua Muntner; Executive Director, CIBC World Markets
- Linda C. Hogan; Executive in Residence, Care Capital LLC
- J. Donald deBethizy, Ph.D.; President and CEO, Targacept, Inc.
- Matthew Perry; Portfolio Manager, Biotechnology Value Fund, L.P.
- Scott Salka; Chief Executive Officer, Ambit Biosciences